Riskpilot← Back to searchSign inGet full accessI-LABS AS
ASActiveOrg 929759699Arnulf Øverlands Vei 198, 0763 OsloComputer consultancy and computer facilities management activities · NACE 6220Est. 20220 employees
Revenue 2024
NOK 0
EBITDA margin
—
+95% vs 2023
Equity ratio
106.2%
Financial strength
Net profit 2024
NOK -3K
+95% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -3K | +95% |
| Net profit | NOK -3K | +95% |
| Total assets | NOK 20K | +231% |
| Equity | NOK 21K | +179% |
| Employees | 0 | — |
Legal name
I-LABS AS
Org number
929759699
Legal form
Aksjeselskap
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
7. september 2022
Share capital
NOK 30 500
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
It konsulenttjenster og forretningsrådgivning.
Address
Arnulf Øverlands Vei 198, 0763 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 9 | 28 | 0 |
| Staff expenses | −0 | −29 | −5 |
| EBITDA | −2 | −54 | −3 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | −2 | −54 | −3 |
| Net financials | 0 | 0 | −0 |
| Profit before tax | −2 | −54 | −3 |
| Tax | −0 | −0 | −0 |
| Net profit | −2 | −54 | −3 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 31 | 6 | 20 |
| Equity | 28 | −26 | 21 |
| Long-term debt | 0 | 19 | 0 |
| Short-term debt | 4 | 13 | −1 |
| Total debt | 4 | 32 | −1 |
EBITDA margin
-287400.0%
This company
15.8%
Market median
-1819087% vs market
20222024
Equity ratio
106.2%
This company
38.2%
Market median
+178% vs market
20222024
Return on equity
-13.8%
This company
18.4%
Market median
-175% vs market
20222024
Net profit margin
-287800.0%
This company
8.1%
Market median
-3553186% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
-0.06×
This company
0.62×
Market median
+110% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
TM Chief Executive Officer | Chief Executive Officer | 2023 – 2023 |
CH Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
MI Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2024 | |
| Former (3) | ||
| Board of Directors | 2023 – 2024 | |
| Chairman | 2022 – 2023 | |
| Chairman | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of I-LABS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tor Morten Kristensen | Chief Executive Officer | 0 companies |
| Carl-Ivar Herskedal Klemetsen | Chief Executive Officer | 0 companies |
| Mohammed Inaam Sheriffdeen | Chief Executive Officer | 0 companies |
| Lise Beate Bjerknes | Board of Directors | 0 companies |
| Mandisa Nadia Mauring | Chairman | 0 companies |
| Carl-Ivar Klemetsen Herskedal | Chairman | 0 companies |
| Achmad Subhan Nasir | Chairman | 0 companies |